Skip to main content
. 2021 Apr 15;11(13):6293–6314. doi: 10.7150/thno.57177

Figure 5.

Figure 5

(A) ImmunoPET and (B) Cerenkov luminescence imaging of mice injected with 86Y-labeled and 90Y-labeled ALT836, respectively. The high uptake of tracer in the tumor visualized by immunoPET is recapitulated with high uptake of the RIT observed by Cherenkov luminescence imaging. Adapted with permission from Ferreira, C.A., et al. 86/90Y-Labeled Monoclonal Antibody Targeting Tissue Factor for Pancreatic Cancer Theranostics. Mol. Pharm. 2020, 17 (5), 1697-1705. Copyright 2020 American Chemical Society.